Eizaburo Ohno, Teiji Kuzuya, Naoto Kawabe, Kazunori Nakaoka, Hiroyuki Tanaka, Takuji Nakano, Kohei Funasaka, Ryoji Miyahara, Senju Hashimoto, Yoshiki Hirooka. Current status of endoscopic ultrasound in the diagnosis of intraductal papillary mucinous neoplasms. DEN open. 2025. 5. 1. e413
Yuichiro Uchida, Tadashi Fujii, Hideaki Takahashi, Kazunori Nakaoka, Kohei Funasaka, Eizaburo Ohno, Yoshiki Hirooka, Takeshi Takahara, Koichi Suda, Takumi Tochio. Alterations in the Gut Microbiota in Patients with Long-Term Follow-Up after Pancreaticoduodenectomy and Their Association with Postoperative Fatty Liver: A Pilot Study. Pancreatology. 2024
Tadashi Fujii, Teiji Kuzuya, Nobuhiro Kondo, Kohei Funasaka, Eizaburo Ohno, Yoshiki Hirooka, Takumi Tochio. Altered intestinal Streptococcus anginosus and 5α-reductase gene levels in patients with hepatocellular carcinoma and elevated Bacteroides stercoris in atezolizumab/bevacizumab non-responders. Journal of medical microbiology. 2024. 73. 9
Kazunori Nakaoka, Eizaburo Ohno, Kento Kuramitsu, Teiji Kuzuya, Kohei Funasaka, Takumi Tochio, Tadashi Fujii, Hideaki Takahashi, Nobuhiro Kondo, Ryoji Miyahara, et al. Efficacy of 1-Kestose Supplementation in Patients with Pancreatic Ductal Adenocarcinoma: A Randomized Controlled Pilot Study. Nutrients. 2024. 16. 17. 2889-2889
Teiji Kuzuya, Naoto Kawabe, Hisanori Muto, Yuryo Wada, Gakushi Komura, Takuji Nakano, Hiroyuki Tanaka, Kazunori Nakaoka, Eizaburo Ohno, Kohei Funasaka, et al. Early Changes in Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin Are Useful Predictors of Antitumor Response to Durvalumab Plus Tremelimumab Therapy for Advanced Hepatocellular Carcinoma. Current oncology (Toronto, Ont.). 2024. 31. 8. 4225-4240